prof. RNDr. Alois Kozubík, CSc.
profesor – Oddělení fyziologie a imunologie živočichů
kancelář: bud. D36/125
Kamenice 753/5
625 00 Brno
telefon: | 549 49 8620 |
---|---|
e‑mail: |
Počet publikací: 231
2018
-
The fibroblast surface markers FAP, anti-fibroblast, and FSP are expressed by cells of epithelial origin and may be altered during epithelial-to-mesenchymal transition
Cytometry Part A, rok: 2018, ročník: 93A, vydání: 9, DOI
2017
-
Activation of autophagy and PPAR gamma protect colon cancer cells against apoptosis induced by interactive effects of butyrate and DHA in a cell type-dependent manner: The role of cell differentiation
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, rok: 2017, ročník: 39, vydání: January, DOI
-
Butyrate alters expression of cytochrome P450 1A1 and metabolism of benzo[a] pyrene via its histone deacetylase activity in colon epithelial cell models
ARCHIVES OF TOXICOLOGY, rok: 2017, ročník: 91, vydání: 5, DOI
-
Butyrate plays a supporting role in alterations of lipidome induced by DHA in colon cancer cells
Rok: 2017, druh: Konferenční abstrakty
-
Cisplatin or LA-12 enhance killing effects of TRAIL in prostate cancer cells through Bid-dependent stimulation of mitochondrial apoptotic pathway but not caspase-10
Plos one, rok: 2017, ročník: 12, vydání: 11, DOI
-
Dietary fatty acids specifically modulate phospholipid patternin colon cells with distinct differentiation capacities
European Journal of Nutrition, rok: 2017, ročník: 56, vydání: 4, DOI
-
Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells
Neoplasia, rok: 2017, ročník: 19, vydání: 10, DOI
-
n-3 Polyunsaturated fatty acids alleviate benzo[a]pyrene toxicity in human colon cancer cell lines
Rok: 2017, druh: Konferenční abstrakty
2016
-
Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia.
Clinical cancer research, rok: 2016, ročník: 22, vydání: 2, DOI
-
CASEIN KINASE 1 INHIBITORS FOR THE TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
Vydavatel: Canadian Intellectual Property Office, stát vydání: Kanada, číslo patentu: CA 2876908, rok: 2016